Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00175019
Status:
COMPLETED
Last Update Posted:
2010-07-27
First Post:
2005-09-12
Brief Title:
Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
Sponsor:
Takeda
Organization:
Takeda
Organization Data
Organization:
Takeda
Class:
INDUSTRY
Study ID:
C02-021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Takeda
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Sr VP Clinical Science
Old Organization:
Takeda Global Research Development Center Inc